Moleculin Biotech, Inc. Reports Financial Results for the Third Quarter Ended September 30, 2016
HOUSTON, TX--(Marketwired - November 21, 2016) - Moleculin Biotech, Inc., (NASDAQ: MBRX) ("Moleculin" or the "Company"), a preclinical and clinical-stage pharmaceutical company focused on the development of anti-cancer drug candidates, …